Miralax

NURS 1566 Clinical Form 3: Clinical Medications Worksheets (You will need to make additional copies of these forms) Generic Name Trade polyethylene Name glycol MiraLax Peak Onset 2-4 days Unknown

Classification Therapeutic: laxatives Pharmacologic: osmotics

Duration Unknown

Dose 17g in 8 oz liquid

Route PO

Time/frequency Once/ Now

Normal dosage range 17g. (One heaping teaspoon) in 8 oz. of water may be used for up to two weeks

Why is your patient getting this medication Constipation

For IV meds, compatibility with IV drips and/or solutions N/A

Mechanism of action and indications (Why med ordered)

Nursing Implications (what to focus on) Contraindications/warnings/interactions

Acts as an osmotic agent, drawing water into the lumen of the GI tract. Indicated for evacuation of the GI tract without water or electrolyte imbalance.

GI obstruction, Gastric retention, Toxic colitis, Megacolon/ Use cautiously in Abdominal pain of uncertain cause, particularly if accompanied by fever/ No significant interactions

Common side effects abdominal bloating, cramping, flatulence, nausea,

Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically) none

Lab value alterations caused by medicine None found Be sure to teach the patient the following about this medication Inform patient that 2-4 days may be required to produce a bowel movement. PEG should not be used for more than 2 wk. Prolonged, frequent, or excessive use may result in electrolyte imbalance and laxative dependence. Advise patient to notify health care professional if unusual cramps, bloating, or diarrhea occurs

Nursing Process- Assessment (Pre-administration assessment) Assess patient for abdominal distention, presence of bowel sounds, and usual pattern of bowel function

Assessment Why would you hold or not give this med? Diarrhea, obstruction

Evaluation Check after giving A soft, formed bowel movement